SCHEMBL8062813

SCHEMBL8062813

C=CCC(c1ccc(Cl)c(Cl)c1)C(C)N

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.41
SLC6A4 P31645 15/20 0.38
SLC6A2 P23975 14/20 0.38
SLC6A3 Q01959 14/20 0.38
CYP3A4 P08684 10/20 0.38
CYP2D6 P10635 10/20 0.38
KCNH2 Q12809 7/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8062809 1.00 PNMT (0.41) PNMTSLC6A4SLC6A2SLC6A3CYP3A4
SCHEMBL8580760 1.00 PNMT (0.41) PNMTSLC6A4SLC6A2SLC6A3CYP3A4
SCHEMBL8105513 0.81 SLC6A2 (0.43) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL8880185 0.81 SLC6A2 (0.40) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL8564048 0.81 SLC6A2 (0.40) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL11580923 0.78 PNMT (0.44) PNMTSLC6A4SLC6A2SLC6A3CYP3A4
SCHEMBL7498979 0.76 SLC6A2 (0.38) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL8101480 0.73 SLC6A3 (0.40) PNMTSLC6A4SLC6A2SLC6A3CYP3A4
SCHEMBL8332281 0.73 SLC6A3 (0.40) PNMTSLC6A4SLC6A2SLC6A3CYP3A4
SCHEMBL8625916 0.73 SLC6A2 (0.51) PNMTSLC6A4SLC6A2SLC6A3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013652-A ANTIINFLAMMATORY AGENTS; ANALGESICS; ANTIHISTAMINES MERCK & CO., INC. (US) 2000-01-11 US disclosed
US-5962462-A COMPOUNDS WHICH INHIBIT THE ENTRY OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTO TARGET CELLS; DELAYING THE ONSET OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS). MERCK & CO., INC. (US) 1999-10-05 US disclosed
EP-0702681-A1 SPIRO-SUBSTITUTED AZACYCLES AS NEUROKININ ANTAGONISTS MERCK & CO. INC. (US) 1996-03-27 EP disclosed
WO-1994029309-A1 SPIRO-SUBSTITUTED AZACYCLES AS NEUROKININ ANTAGONISTS MERCK & CO., INC. (US) 1994-12-22 WO disclosed